Back

Artificial intelligence-based predicting incident atrial fibrillation using sinus rhythm electrocardiogram for post-myocardial infarction patients as an image data structure

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Atrial tachyarrhythmias Diagnostic Methods EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Associate Professor In-Soo Kim

Gangnam Severance Hospital, Seoul (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Serial arterial blood gas monitoring during deep sedation for left atrial ablation procedures: a retrospective cohort study
Doctor V. Buia (Fuerth, DE)
Abstract Slides Video
Presentation thumbnail
Analysis of inflammatory and oxidative stress markers in radiofrequency and PFA for atrial fibrillation
Doctor N. Pierucci (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Correlation between tracheal carina angle and recurrence in atrial fibrillation patients undergoing catheter ablation: Is epicardial reactivation the major game changer in AF ablation success?
Doctor Y. YAMANTURK (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Improvement in mitral and tricuspid regurgitation in patients with atrial fibrillation after restoration of sinus rhythm - a prospective cohort study
Doctor F. Schwarz (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation source ablation guided by preferential conduction directions is superior to conventional ablation strategies in preventing re-initiation in a realistic 3D in-silico model
Mr V. Goncalves Marques (Maastricht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial tachyarrhythmias

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Interactive discussion and Q&A
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - discussion

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources